Geoffrey T. Yarranton
2011
In 2011, Geoffrey T. Yarranton earned a total compensation of $284K as Chief Scientific Officer & Executive Vice President, Research and Development at KaloBios Pharmaceuticals.
Compensation breakdown
| Salary | $275,000 |
|---|---|
| Stock Awards | $9,020 |
| Total | $284,020 |
Yarranton received $275K in salary, accounting for 97% of the total pay in 2011.
Yarranton also received $9K in stock awards.
Rankings
In 2011, Geoffrey T. Yarranton's compensation ranked 9,509th out of 10,747 executives tracked by ExecPay. In other words, Yarranton earned more than 11.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,509 out of 10,747 | 12th |
Division Manufacturing | 3,541 out of 3,960 | 11th |
Major group Chemicals And Allied Products | 905 out of 1,033 | 12th |
Industry group Drugs | 680 out of 781 | 13th |
Industry Pharmaceutical Preparations | 508 out of 571 | 11th |
Source: SEC filing on October 29, 2012.
Yarranton's colleagues
We found two more compensation records of executives who worked with Geoffrey T. Yarranton at KaloBios Pharmaceuticals in 2011.